Publications

Detailed Information

Characterization of molecular subtypes of Korean breast cancer: An ethnically and clinically distinct population

DC Field Value Language
dc.contributor.authorHan, Wonshik-
dc.contributor.authorNicolau, Monica-
dc.contributor.authorNoh, Dong-Young-
dc.contributor.authorJeffrey, Stefanie S.-
dc.date.accessioned2012-06-29T08:09:25Z-
dc.date.available2012-06-29T08:09:25Z-
dc.date.issued2010-07-
dc.identifier.citationINTERNATIONAL JOURNAL OF ONCOLOGY; Vol.37, no.1; 51-59ko_KR
dc.identifier.issn1019-6439-
dc.identifier.urihttps://hdl.handle.net/10371/77983-
dc.description.abstractWe aimed to investigate the molecular characteristics of Korean breast cancer. A cDNA microarray study (>42k clones) was performed on 69 breast cancers and three normal breast tissues. The subjects had a high percentage of HER-2 expression, hormone receptor negativity, and young onset. Molecular subtypes according to gene expression profiles were determined and their correlations to the clinicopathologic characteristics and patients outcome were analyzed. The tumors were subdivided into luminal-, normal breast-like, ERBB2(+), and basal-like subtypes according to the correlations to the previously described intrinsic genes and five centroids. Only a few tumors were highly correlated to the luminal B and normal-like centroids. The high grade tumors with high p53 and Ki-67 were found more commonly in non-luminal tumors. Distant recurrence-free survival was worse in ERBB2(+) and basal-like subgroups than luminal tumors. In an unsupervised clustering, with 864 genes, many interesting gene clusters were observed, some of which had not been previously described. Although the Korean breast cancers showed generally similar molecular phenotypes as Western studies, some distinct gene expression patterns and their association to clinical outcomes were observed.ko_KR
dc.language.isoenko_KR
dc.publisherSPANDIDOS PUBL LTDko_KR
dc.subjectbreast neoplasmsko_KR
dc.subjectraceko_KR
dc.subjectAsianko_KR
dc.subjectgene expression profilingko_KR
dc.subjectprognosisko_KR
dc.titleCharacterization of molecular subtypes of Korean breast cancer: An ethnically and clinically distinct populationko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor한원식-
dc.contributor.AlternativeAuthor노동영-
dc.identifier.doi10.3892/ijo_00000652-
dc.citation.journaltitleINTERNATIONAL JOURNAL OF ONCOLOGY-
dc.description.citedreferenceJung SY, 2009, ANN SURG ONCOL, V16, P1112, DOI 10.1245/s10434-009-0334-7-
dc.description.citedreferenceAhn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754-
dc.description.citedreferenceChang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102-
dc.description.citedreferenceHan WS, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-82-
dc.description.citedreferenceSloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062-
dc.description.citedreferenceSagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029-
dc.description.citedreferenceNielsen TO, 2004, CLIN CANCER RES, V10, P5367-
dc.description.citedreferenceDontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011-
dc.description.citedreferenceChoi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179-
dc.description.citedreferenceWiencke JK, 2004, NAT REV CANCER, V4, P79, DOI 10.1038/nrc1257-
dc.description.citedreferenceAhn SH, 2004, ARCH SURG-CHICAGO, V139, P27-
dc.description.citedreferenceKun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347-
dc.description.citedreferenceChoi DH, 2003, CANCER, V98, P1587, DOI 10.1002/cncr.11703-
dc.description.citedreferenceSotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100-
dc.description.citedreferenceSorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100-
dc.description.citedreferenceWilliams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503-
dc.description.citedreferenceGollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078-
dc.description.citedreferencevan de Rijn M, 2002, AM J PATHOL, V161, P1991-
dc.description.citedreferenceTibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567-
dc.description.citedreferenceYoo KY, 2002, J KOREAN MED SCI, V17, P1-
dc.description.citedreferencevan`t Veer LJ, 2002, NATURE, V415, P530-
dc.description.citedreferenceZhao HJ, 2002, BMC GENOMICS, V3-
dc.description.citedreferenceFinlin BS, 2001, J BIOL CHEM, V276, P42259-
dc.description.citedreferenceWest M, 2001, P NATL ACAD SCI USA, V98, P11462-
dc.description.citedreferenceSorlie T, 2001, P NATL ACAD SCI USA, V98, P10869-
dc.description.citedreferenceGruvberger S, 2001, CANCER RES, V61, P5979-
dc.description.citedreferenceTroyanskaya O, 2001, BIOINFORMATICS, V17, P520-
dc.description.citedreferenceSherlock G, 2001, NUCLEIC ACIDS RES, V29, P152-
dc.description.citedreferencePerou CM, 2000, NATURE, V406, P747-
dc.description.citedreferencePerou CM, 1999, P NATL ACAD SCI USA, V96, P9212-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share